Magungunan rigakafin farfaɗo Magani Grade Pharma Matsakaicin Zafafan siyarwar Foda Allunan CAS 148553-50-8

                                               CAS 148553-50-8 Amfani:

CAS 148553-50-8 analog ne na neurotransmitter gamma-aminobutyric acid (GABA), wanda aka sayar a ƙarƙashin sunan kasuwanci.A cikin Disamba 2004, FDA ta amince da CAS 148553-50-8 a matsayin magani don maganin neuralgia na ciwon sukari da herpes zoster neuralgia.CAS 148553-50-8 shine magani na farko da aka amince da shi a Amurka da Turai don maganin ciwon daji. sama da nau'ikan zafi guda biyu.A cikin watan Yuni 2005, an amince da CAS 148553-50-8 don maganin jinyar balagaggu na farfaɗowa.A cikin Maris 2006, Ƙungiyar Tarayyar Turai ta amince da CAS 148553-50-8 don maganin rashin jin daɗi na gaba ɗaya (GAD) da kuma rashin jin dadin jama'a (SAD).
              
CAS 148553-50-8 ana amfani da shi musamman don maganin neuralgia na gefe da kuma jiyya na juzu'i na ɓangarori na yanki.
CAS 148553-50-8 na iya rage sakin dogaro da calcium na wasu neurotransmitters ta hanyar daidaita aikin tashar calcium.Ko da yake CAS 148553-50-8 wani tsari ne wanda aka samo asali na inhibitory neurotransmitter γ-aminobutyric acid (GABA), ba ya ɗaure kai tsaye ga GABAA, GABAB, ko masu karɓar benzodiazepine kuma baya ƙara GABAA a cikin Amsar neurons na al'ada, bai canza ba. maida hankali na GABA a cikin kwakwalwar berayen, kuma ba shi da wani tasiri mai mahimmanci akan ɗauka ko lalata GABA.Duk da haka, binciken ya gano cewa tsawaita bayyanuwa na neurons na al'ada zuwa CAS 148553-50-8 ya kara yawan masu jigilar GABA da ƙimar jigilar GABA mai aiki.CAS 148553-50-8 baya toshe tashoshin sodium, ba shi da wani aiki akan masu karɓar opioid, baya canza ayyukan cyclooxygenase, ba shi da wani aiki akan masu karɓa na dopamine da serotonin, kuma baya hana sake kunna dopamine, serotonin, ingest.